We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.05B
AUM Growth
+$259M
Cap. Flow
+$4.36M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.09%
Holding
255
New
12
Increased
112
Reduced
101
Closed
15

Sector Composition

Rank Sector Weight
1 Healthcare 33.48%
2 Technology 28.09%
3 Industrials 14.98%
4 Consumer Discretionary 7.96%
5 Communication Services 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
151
Cisco
CSCO
$439B
$2.72M 0.13%
23,166
-6,266
-21% -$655K
GFF icon
152
Griffon
GFF
$4.38B
$2.69M 0.13%
27,623
-14,661
-35% -$1.28M
BLND icon
153
Blend Labs
BLND
$345M
$2.67M 0.13%
1,560,021
+553,732
+55% +$883K
PLOW icon
154
Douglas Dynamics
PLOW
$939M
$2.63M 0.13%
48,776
-5,956
-11% -$275K
OLED icon
155
Universal Display
OLED
$3.85B
$2.6M 0.13%
30,023
+8,310
+38% +$767K
RGEN icon
156
Repligen
RGEN
$9.35B
$2.57M 0.13%
18,833
-1,318
-7% -$162K
ENSG icon
157
The Ensign Group
ENSG
$10.1B
$2.53M 0.12%
15,777
-121
-0.8% -$21.3K
VFC icon
158
VF Corp
VFC
$5.17B
$2.51M 0.12%
150,597
+36,905
+32% +$660K
TKO icon
159
TKO Group
TKO
$13.9B
$2.5M 0.12%
12,432
-902
-7% -$176K
PLBC icon
160
Plumas Bancorp
PLBC
$433M
$2.48M 0.12%
42,412
+5,271
+14% +$279K
WLDN icon
161
Willdan Group
WLDN
$1.25B
$2.42M 0.12%
30,579
+1,367
+5% +$116K
LIND icon
162
Lindblad Expeditions
LIND
$1.71B
$2.41M 0.12%
85,391
-52,905
-38% -$1.12M
VMD icon
163
Viemed Healthcare
VMD
$332M
$2.38M 0.12%
209,066
-21,316
-9% -$211K
XERS icon
164
Xeris Biopharma Holdings
XERS
$1.37B
$2.38M 0.12%
300,791
+49,725
+20% +$318K
PCRX icon
165
Pacira BioSciences
PCRX
$1.01B
$2.37M 0.12%
93,396
+4,552
+5% +$108K
ANIP icon
166
ANI Pharmaceuticals
ANIP
$1.62B
$2.36M 0.12%
28,562
+1,746
+7% +$140K
ALG icon
167
Alamo Group
ALG
$2.05B
$2.28M 0.11%
13,834
+4,542
+49% +$735K
SPB icon
168
Spectrum Brands
SPB
$1.98B
$2.23M 0.11%
25,999
-6,051
-19% -$490K
NVDA icon
169
NVIDIA
NVDA
$5.29T
$2.22M 0.11%
11,111
-4,290
-28% -$882K
ALKT icon
170
Alkami Technology
ALKT
$2B
$2.2M 0.11%
121,675
+57,348
+89% +$947K
TCMD icon
171
Tactile Systems Technology
TCMD
$503M
$2.2M 0.11%
74,022
-21,543
-23% -$541K
OMCL icon
172
Omnicell
OMCL
$1.49B
$2.15M 0.1%
51,789
-5,725
-10% -$231K
VVX icon
173
V2X
VVX
$2.29B
$2.14M 0.1%
28,733
-11,946
-29% -$889K
ON icon
174
ON Semiconductor
ON
$28.8B
$2.11M 0.1%
22,365
-1,640
-7% -$168K
SMP icon
175
Standard Motor Products
SMP
$862M
$2.11M 0.1%
54,230
+2,682
+5% +$103K

Similar funds

Rice Hall James & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Rice Hall James & Associates held 255 positions worth $2.05B, up 14% from $1.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q2 2026 filing shows 12 new, 112 increased, 101 reduced and 15 closed positions. Its largest new stake was Oshkosh: 106,011 shares worth $16.3M. The largest sale was Aehr Test Systems, an estimated $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q2 2026 buy was Oshkosh: 106,011 shares worth $16.3M.
  • Rice Hall James & Associates added most to Upwork in Q2 2026, an estimated $13.9M increase.
  • Rice Hall James & Associates's biggest Q2 2026 reduction was Aehr Test Systems, cutting an estimated $16.9M.
  • Rice Hall James & Associates fully exited Amicus Therapeutics in Q2 2026, selling an estimated $11.1M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.05B portfolio in Q2 2026.
  • Rice Hall James & Associates opened 12 new positions and closed 15 in Q2 2026.
  • Rice Hall James & Associates's portfolio value rose 14% quarter-over-quarter to $2.05B.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.